Search

Your search keyword '"Harbo T."' showing total 135 results

Search Constraints

Start Over You searched for: Author "Harbo T." Remove constraint Author: "Harbo T."
135 results on '"Harbo T."'

Search Results

1. Electrodiagnostic subtyping in Guillain–Barré syndrome patients in the International Guillain–Barré Outcome Study

2. CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome

3. Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data

5. Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data

6. Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data

7. Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values

8. Predicting Outcome in Guillain-Barre Syndrome International Validation of the Modified Erasmus GBS Outcome Score

9. Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: An international observational study

10. Guillain-Barré syndrome following SARS-CoV-2 infection in the international GBS outcome study

11. Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study

12. Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score

13. Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome. An international observational study

14. Current treatment practice of Guillain-Barré syndrome

15. ‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab

16. Consistent improvement with eculizumab across muscle groups in myasthenia gravis

17. Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study

20. Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab:subgroup analysis of REGAIN and its extension study

21. Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study

22. International Guillain-Barré Syndrome Outcome Study

25. Current treatment practice of Guillain-Barré syndrome

26. Eculizumab Improves Fatigue in Refractory Generalized Myasthenia Gravis

27. ‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab

28. Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study

32. Regional variation of Guillain-Barré syndrome

33. International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome

36. Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis (Quality of Life Research, (2019), 28, 8, (2247-2254), 10.1007/s11136-019-02148-2)

37. Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data

38. Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke

39. Regional variation of Guillain-Barré syndrome

40. Protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome

41. Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data

42. Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data

43. INTERNATIONAL GUILLAIN-BARRE SYNDROME OUTCOME STUDY (IGOS): DESCRIPTION OF THE FIRST 1000 PATIENTS

44. International Guillain-Barre Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barre syndrome

45. International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome

47. PROGRESS OF INTERNATIONAL GUILLAIN-BARRE STUDY (IGOS): A PROSPECTIVE STUDY ON CLINICAL AND BIOLOGICAL PREDICTORS OF DISEASE COURSE AND OUTCOME

48. PROGRESS OF INTERNATIONAL GUILLAIN-BARRE STUDY (IGOS): A PROSPECTIVE STUDY ON CLINICAL AND BIOLOGICAL PREDICTORS OF DISEASE COURSE AND OUTCOME

49. Subcutaneous immunoglobulin preserves muscle strength in chronic inflammatory demyelinating polyneuropathy

Catalog

Books, media, physical & digital resources